Search

Your search keyword '"Lacasce, A. S."' showing total 199 results

Search Constraints

Start Over You searched for: Author "Lacasce, A. S." Remove constraint Author: "Lacasce, A. S." Search Limiters Peer Reviewed Remove constraint Search Limiters: Peer Reviewed
199 results on '"Lacasce, A. S."'

Search Results

3. A multi-cohort phase 1b trial of rituximab in combination with immunotherapy doublets in relapsed/refractory follicular lymphoma

4. Real-World Multicenter Study of PD-1 Blockade in HIV-Associated Classical Hodgkin Lymphoma Across the United States

7. Five-year follow-up of a phase 2 study of ibrutinib plus fludarabine, cyclophosphamide, and rituximab as initial therapy in CLL

9. A phase 1b study of ibrutinib in combination with obinutuzumab in patients with relapsed or refractory chronic lymphocytic leukemia

11. Minimal residual disease in patients with diffuse large B-cell lymphoma undergoing autologous stem cell transplantation

12. A phase 2 study of pembrolizumab after autologous stem cell transplantation in patients with T-cell non-Hodgkin lymphoma

16. The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee

17. Phase II Study of Acalabrutinib, Venetoclax, and Obinutuzumab in a Treatment-Naïve Chronic Lymphocytic Leukemia Population Enriched for High-Risk Disease.

19. Acalabrutinib, venetoclax, and obinutuzumab as frontline treatment for chronic lymphocytic leukaemia: a single-arm, open-label, phase 2 study

21. Spatial signatures identify immune escape via PD-1 as a defining feature of T-cell/histiocyte-rich large B-cell lymphoma

22. PD-1 blockade for diffuse large B-cell lymphoma after autologous stem cell transplantation

25. Ibrutinib plus fludarabine, cyclophosphamide, and rituximab as initial treatment for younger patients with chronic lymphocytic leukaemia: a single-arm, multicentre, phase 2 trial

26. PD-1 blockade with pembrolizumab for classical Hodgkin lymphoma after autologous stem cell transplantation

28. Positron emission tomography–computed tomography predictors of progression after DA-R-EPOCH for PMBCL

30. Immune Reconstitution following High-Dose Chemotherapy and Autologous Stem Cell Transplantation with or without Pembrolizumab Maintenance Therapy in Patients with Lymphoma

33. Effect of atorvastatin versus placebo on efficacy in patients with diffuse large B-cell lymphoma receiving R-CHOP.

34. The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice

39. An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era

41. Selective CDK4/6 inhibition with tumor responses by PD0332991 in patients with mantle cell lymphoma

46. Navitoclax, a targeted high-affinity inhibitor of BCL-2, in lymphoid malignancies: a phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour activity

Catalog

Books, media, physical & digital resources